Cat. No. | Product name | CAS No. |
DCC2972 |
Kt-182
Potent and selective inhibitor of ABHD6 |
1402612-62-7 |
DCC2973 |
Kt2-962
TXA2/prostaglandin endoperoxide receptor antagonist |
129648-96-0 |
DCC2974 |
Kta-439
Thyroid hormone receptor β (TRβ) selective agonist |
575503-70-7 |
DCC2975 |
Ku-2285
Hypoxic cell radiosensitizer |
121077-11-0 |
DCC2976 |
Kufal194
Novel selective DYRK1A inhibitor |
|
DCC2977 |
Kunb31
Novel potent and selective inhibitor of Hsp90β |
2220263-80-7 |
DCC2978 |
Kurasoin B
Novel protein farnesyltransferase inhibitor |
193696-42-3 |
DCC2979 |
kv1.5-in-iiii
Potent Kv1.5 inhibitor |
1469902-72-4 |
DCC2980 |
Kv2.1/syntaxin-in-cpd5
Novel neuroprotectant, inhibiting Kv2.1-syntaxin molecular interaction |
|
DCC2981 |
Kva-d-88
Novel Preferable Phosphodiesterase 4B (PDE4B) Inhibitor, Decreasing Cocaine-Mediated Reward Properties in Vivo |
2410550-31-9 |
DCC2982 |
Ky1022
Ras destabilizer, targeting the Wnt/ß-catenin pathway and inhibiting development of metastatic colorectal cancer |
1029721-36-5 |
DCC2983 |
Kya1797
Novel inhibitor of the Wnt/ß-catenin pathway, binding directly to the regulators of G-protein signaling domain of axin, initiating ß-catenin and Ras degradation through enhancement of the ß-catenin destruction complex activating GSK3ß, effectively suppres |
851304-36-4 |
DCC2984 |
Kys05047
Selective T-type Ca(2+) channel blocker with anti-proliferative effects against various cancer cells |
839672-57-0 |
DCC2985 |
L-161240
Potent inhibitor of LpxC and lipid A biosynthesis |
183298-68-2 |
DCC2986 |
L-162782
Nonpeptide agonist of angiotensin AT1 receptor |
169281-92-9 |
DCC2987 |
L17er4
Novel cell-permeable attenuated cationic amphiphilic lytic (ACAL) peptide, efficiently bring immunoglobulin G (IgG) and other functional proteins into cells |
|
DCC2988 |
L2-4048
Novel Migration Inhibitory Factor (MIF) inhibitor, binding at the allosteric and tautomerase sites, blocking MIF's tautomerase CD74 receptor binding, and pro-inflammatory activities |
|
DCC2989 |
L458-bpyne
Novel γ-secretase modulator photoaffinity probe, identifying distinct allosteric binding sites on presenilin that can be exploited to reduce levels of pathogenic Aβ species |
1374647-07-0 |
DCC2990 |
L465046 (α-synuclein Amyloid Aggregation Inhibitor)
Novel inhibitor of α-synuclein amyloid aggregation for the treatment of Parkinson's disease |
675171-18-3 |
DCC2991 |
L524-0366
Novel inhibitor of the TWEAK-Fn14 signaling cascade |
951612-19-4 |
DCC2992 |
L61h46
Novel potent inhibitor of human pancreatic cancer cells |
|
DCC2993 |
L-651392
Potent leukotriene inhibitor |
93211-49-5 |